Rapport Therapeutics, Inc (RAPP) insider trading
Every open-market stock purchase and sale by Rapport Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- James Healy (Board member) and 6 others bought $22M in the last 90 days, growing their stake 55%.
- Abraham Ceesay (CEO) and 2 others sold $6.9M in the last 90 days.
Last 12 months: insiders bought $22M (7 buys) and sold $47.2M (34 sales). Last close $25.05 on Oct 30, 2026.
Recent RAPP insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 28, 2026 | James Healy (Director) | Bought | $20M |
| Oct 28, 2026 | James Healy (Director) | Bought | $146K |
| Oct 28, 2026 | James Healy (Director) | Bought | $134K |
| Oct 28, 2026 | James Healy (Director) | Bought | $79.2K |
| Oct 23, 2026 | Ramiro Sanchez (Insider) | Bought | $98.5K |
| Oct 22, 2026 | Steven M Paul (Insider) | Bought | $974K |
| Oct 22, 2026 | John Maraganore (Insider) | Bought | $217K |
| Oct 22, 2026 | Wendy B. Young (Insider) | Bought | $100K |
| Oct 22, 2026 | Paul M Silva (Insider) | Bought | $99.6K |
| Oct 22, 2026 | John Maraganore (Insider) | Bought | $31.5K |
| Oct 21, 2026 | Troy A. Ignelzi (CFO) | Bought | $144K |
| Oct 21, 2026 | Abraham Ceesay (CEO) | Sold | $64.4K |
| Oct 7, 2026 | Abraham Ceesay (CEO) | Sold | $35.2K |
| Oct 6, 2026 | Abraham Ceesay (CEO) | Sold | $108K |
| Sep 30, 2026 | Cheryl Gault (COO) | Sold | $262K |
| Sep 30, 2026 | Cheryl Gault (COO) | Sold | $70K |
| Sep 23, 2026 | Abraham Ceesay (CEO) | Sold | $76.2K |
| Sep 23, 2026 | Abraham Ceesay (CEO) | Sold | $8.6K |
| Sep 23, 2026 | Abraham Ceesay (CEO) | Sold | $1.8K |
| Sep 8, 2026 | Abraham Ceesay (CEO) | Sold | $325K |
| Sep 8, 2026 | Abraham Ceesay (CEO) | Sold | $49.2K |
| Aug 25, 2026 | Krishnaswamy Yeleswaram (C-suite exec) | Sold | $1M |
| Aug 25, 2026 | Abraham Ceesay (CEO) | Sold | $938K |
| Aug 25, 2026 | Krishnaswamy Yeleswaram (C-suite exec) | Sold | $827K |
| Aug 24, 2026 | Krishnaswamy Yeleswaram (C-suite exec) | Sold | $658K |
Who's trading RAPP
- James Healy, Director: bought $20.4M (4 buys), last Oct 28, 2026
- Ramiro Sanchez, Insider: bought $98.5K (1 buy), last Oct 23, 2026
- Wendy B. Young, Insider: bought $100K (1 buy), last Oct 22, 2026
- John Maraganore, Insider: bought $249K (2 buys), last Oct 22, 2026
- Steven M Paul, Insider: bought $974K (1 buy), last Oct 22, 2026
- Paul M Silva, Insider: bought $99.6K (1 buy), last Oct 22, 2026
- Troy A. Ignelzi, CFO: bought $144K (1 buy), last Oct 21, 2026
- Abraham Ceesay, CEO: sold $6M (36 sales), last Oct 21, 2026
- Cheryl Gault, COO: sold $1.2M (10 sales), last Sep 30, 2026
- Krishnaswamy Yeleswaram, C-suite exec: sold $4.5M (11 sales), last Aug 25, 2026
- Reid M Huber, Insider: other filings, last Jun 10, 2026
- Robert J Perez, Insider: other filings, last Jun 10, 2026
- Third Rock Ventures V L.P., Insider: sold $34.4M (5 sales), last May 26, 2026
- David Bredt, C-suite exec: sold $1.1M (10 sales), last Feb 19, 2026
- Jeffrey Sevigny, C-suite exec: other filings, last Feb 2, 2026
Get free alerts when an insider at Rapport Therapeutics, Inc files a new trade →